
Anna Amiss graduated from a Bachelor of Science, majoring in Genetics, from the University of Queensland (2013) before undergoing her Master of Science at the University of Otago in New Zealand (2016). She was granted a University of Otago Master’s Scholarship to study the effect of current breast cancer treatments on the immune system. Upon completion, Anna returned to the University of Queensland (UQ) as a research assistant at the Institute for Molecular Bioscience (IMB). In 2017 she began her PhD at IMB, developing peptide-based antimicrobial therapies against Burkholderia infection. Her research involves peptide purification, bacterial growth assays and cell-based assays (cytotoxicity, internalisation studies, flow cytometry).
Dr Anna Amiss was awarded a PhD in July 2022 from UQ.